Cargando…
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in pat...
Autores principales: | Kaiser, Yannick, Nurmohamed, Nick S, Kroon, Jeffrey, Verberne, Hein J, Tzolos, Evangelos, Dweck, Marc R, Somsen, Aernout G, Arsenault, Benoit J, Stroes, Erik S G, Zheng, Kang H, Boekholdt, S Matthijs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666821/ https://www.ncbi.nlm.nih.gov/pubmed/34593533 http://dx.doi.org/10.1136/heartjnl-2021-319804 |
Ejemplares similares
-
Lipoprotein(a) is robustly associated with aortic valve calcium
por: Kaiser, Yannick, et al.
Publicado: (2021) -
Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis
por: Thomassen, Henrik K, et al.
Publicado: (2017) -
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis
por: Lee, Sahmin, et al.
Publicado: (2020) -
Sex-specific correlates of valvular and arterial calcification burden in patients with moderate aortic stenosis
por: Deslandes, Marianne, et al.
Publicado: (2022) -
Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply
por: Kaiser, Yannick, et al.
Publicado: (2023)